Bendamustine monochemotherapy in aggressive or advanced‐stage primary cutaneous T‐cell lymphomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bendamustine monochemotherapy in aggressive or advanced‐stage primary cutaneous T‐cell lymphomas

Published:2022-11-10 Issue:2 Volume:37 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Michalowitz Alena‐Lioba¹^ORCID,Burmann Sven‐Niklas¹^ORCID,Oellig Frank²^ORCID,Assaf Chalid³^ORCID,Cerroni Lorenzo⁴,Kreuter Alexander¹^ORCID

Affiliation:

1. Department of Dermatology, Venerology and Allergology, Helios St. Elisabeth Hospital Oberhausen University Witten/Herdecke Oberhausen Germany

2. Institute of Pathology Mülheim an der Ruhr Germany

3. Department of Dermatology Helios Hospital Krefeld Krefeld Germany

4. Research Unit Dermatopathology, Department of Dermatology Medical University of Graz Graz Austria

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18691

Reference8 articles.

1. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

2. Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy

3. Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi

4. Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

5. Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023;European Journal of Cancer;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3